James Langtry MBBS, LRCP, MRCS, MRCP, FACMS

  • Trained at Charing Cross Hospital, London (1975 – 1980)
  • House jobs, SHO Accident & Emergency, General Medicine in various London and home counties hospitals

Dermatology Training

  • SHO – Westminster Hospital / St Stephens Hospital (1985 – 1986)
  • Clinical observership – Instituto Nacional de Pediatria, Mexico City (August 1986)
  • Registrar – Dryburn Hospital, Durham (1986 – 1989)
  • Registrar Exchange – Hospital Clinic, Barcelona (February & March 1987)
  • Senior Registrar (locum) – Westminster & Chelsea Westminster Hospitals (1989 – 1990)
  • Senior Registrar – City Hospital Birmingham (1990 – 1992)
  • American College of Mohs Surgery (ACMS) fellowship, Vancouver General Hospital, Vancouver, Canada (1996 -1997)

Consultant Dermatologist – Sunderland Royal Hospital (1992 -2005)

Lead clinician at Sunderland Royal Hospital (SRH) and started joint clinics with Oculoplastic Surgery, Maxillofacial Surgery and Rheumatology. Frozen tissue Mohs micrographic surgery (Mohs surgery) and specialist skin surgery lists developed, as well as weekly skin surgery meetings at the RVI.

Established regular GP educational events at SRH, bi-annual RCGP basic skin surgery course, organized Dowling Club meeting at SRH, organized BSDS advanced skin surgery meeting.

Ordinary member Secretary of the British Association of Dermatology (BSDS), member of the Northern Cancer Network (NCN) skin cancer tumour specific subgroup.

Graduated with Diploma of Medical Education from Newcastle University.

Attended ACMS annual meeting in North America each year from 1998.

Consultant Dermatologist & Dermatological Surgeon, RVI Newcastle Upon Tyne (2006 – 2019)

Established Mohs surgery unit, training of Mohs technicians and monthly Mohs technician meetings, monthly Mohs-pathology meetings, Mohs fellowship training program (2 Mohs surgery fellows per year), monthly Mohs surgery fellow review meetings, weekly surgical closures meeting.

Secretary, president-elect and president of the British Society of Dermatological Surgery (BSDS), chair of the NCN skin cancer tumour specific subgroup, chair of the skin cancer MDT at NUTH, program director of Mohs surgery fellowship training.

Vice-chair of UK skin cancer working party.

Co-organized BSDS advanced skin surgery courses, Mohs surgery-Oculoplastic surgery course and BSDS basic skin surgery courses.

Monthly joint clinic with Oculoplastic surgery.

Selected Publications

01
Pre-emptive intra-auricular electrosurgical resurfacing of cylindromas to prevent conductive deafness in CYLD cutaneous syndrome. Langtry J, Rajan N. Br J Dermatol. 2020;183(6):e188
02
Use of a Proximal Peng Flap for Reconstruction of the Nasal Dorsum in 14 Patients. Jayasekera PSA, Hackett C, Oliphant T, Langtry JAA. Dermatol Surg. 2019;45(12):1704-1706.
03
The causes of nail apparatus pigmentation presenting to a melanoma screening clinic a prospective study. Alani A, Blasdale C, Oliphant T, Hackett C, Langtry JAA. Clin Exp Dermatol. 2019;44(6):625-630.
04
Tracking tumor kinetics in patients with germline CYLD mutations. Brown S, Worthy SA, Langtry JAA, Rajan N. J Am Acad Dermatol. 2018;79(5):949-951.
Read here
05
Inherited pulmonary cylindromas: extending the phenotype of CYLD mutation carriers. Brown SM, Arefi M, Stones R, Loo PS, Barnard S, Bloxham C, Stefanos N, Langtry JAA, Worthy S, Calonje E, Husain A, Rajan N. Br J Dermatol. 2018;179(3):662-668.
06
Dermoscopy prior to Mohs micrographic surgery does not improve tumour margin assessment and leads to fewer Mohs stages. Jayasekera PSA, Dodd J, Oliphant T, Langtry JAA, Lawrence CM. Br J Dermatol. 2018;178(2):565-566.
Read here
07
Does the proposed removal of mitotic count as a prognostic indicator in melanoma, accurately reflect the risk profile for metastasis in UK patients? Rannan-Eliya SV, Henton JMD, Callear JHA, Langtry J.J Plast Reconstr Aesthet Surg. 2018;71(2):261-262.
Read here
08
Cutaneous manifestations of phosphate solution extravasation. Verykiou S, Aljefri K, Gopee H, Taheri L, Charlton F, Langtry JA, Blasdale C. Clin Exp Dermatol. 2018;43(1):42-45.
09
Safety, complications and patients’ acceptance of Mohs micrographic surgery under local anaesthesia: results from the U.K. MAPS (Mohs Acceptance and Patient Safety) Collaboration Group. Hussain W, Affleck A, Al-Niaimi F, Cooper A, Craythorne E, Fleming C, Ghura V, Langtry J, Lawrence C, Loghdey S, Naysmith L, Oliphant T, Rahim R, Rice S, Sivaramkrishan M, Stables G, Varma S, Mallipeddi R. Br J Dermatol. 2017;176(3):806-808.
read here
10
The Utility of the “Trap Door Flap” in Dermatological Surgery. Hussain W, Langtry J. Dermatol Surg. 2017;43(1):146-148.
read here
11
Diagnostic biopsy before Mohs micrographic surgery, frequency of change in diagnosis and impact on management. Verykiou S, Oliphant TJ, Rahim R, Husain A, Lawrence CM, Langtry JA. Br J Dermatol. 2016;174(3):649-51.